The pyrazole compound of the present invention is represented by the following general formula (I). The pyrazole compound of the present invention or a salt thereof or a solvate thereof potently inhibits liver glycogen phosphorylase, and, therefore, is useful as a therapeutic or prophylactic agent for diabetes.
wherein each symbol denotes as described in the specifications.
本发明的
吡唑化合物由以下一般式(I)表示。本发明的
吡唑化合物或其盐或溶剂化物强力抑制肝
糖原磷酸化酶,因此,可用作糖尿病的治疗或预防剂。其中,每个符号如规范中所述。